JERUSALEM--(BUSINESS WIRE)--Developing new pipeline assets through the New Therapeutic Entities (NTE) process, which was launched less than one year ago, is a major element in Teva's strategy for growth. Join the Teva In-Focus NTE Webinar on December 4th to learn more about some of the product candidates that the NTE process has produced in 2013.
Help employers find you! Check out all the jobs and post your resume.
